Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma
Neuro-Oncology · 02.06.2023 · 25 (6) · 1073-1084
DOI: 10.1093/neuonc/noac288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 02.01.2023. Verfasst von Yuan Xie und 18 weiteren Autor:innen. Beteiligte Einrichtung: China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural…. Hauptthemen laut MEDLINE: Glioma, Glioblastoma, Brain Neoplasms, Symporters. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Swedish Foundation for International Cooperation in Research and Higher Education (STINT) Mobility Program, Swedish Cancer Foundation.
Abstract (Originalsprache)
Background
Systemic delivery of anti-tumor therapeutic agents to brain tumors is thwarted by the blood-brain barrier (BBB), an organotypic specialization of brain endothelial cells (ECs). A failure of pharmacological compounds to cross BBB is one culprit for the dismal prognosis of glioblastoma (GBM) patients. Identification of novel vascular targets to overcome the challenges posed by the BBB in tumors for GBM treatment is urgently needed.
Methods
Temozolomide (TMZ) delivery was investigated in CT2A and PDGFB-driven RCAS/tv-a orthotopic glioma models. Transcriptome analysis was performed on ECs from murine gliomas. Mfsd2a deficient, Cav1 deficient, and Mfsd2a EC-specific inducible mice were developed to study the underlying molecular mechanisms.
Results
We demonstrated that inhibiting Wnt signaling by LGK974 could increase TMZ delivery and sensitize glioma to chemotherapy in both murine glioma models. Transcriptome analysis of ECs from murine gliomas revealed that Wnt signaling inhibition enhanced vascular transcytosis as indicated by the upregulation of PLVAP and downregulation of MFSD2A. Mfsd2a deficiency in mice enhances TMZ delivery in tumors, whereas constitutive expression of Mfsd2a in ECs suppresses the enhanced TMZ delivery induced by Wnt pathway inhibition in murine glioma. In addition, Wnt signaling inhibition enhanced caveolin-1 (Cav1)-positive caveolae-mediated transcytosis in tumor ECs. Moreover, Wnt signaling inhibitor or Mfsd2a deficiency fails to enhance TMZ penetration in tumors from Cav1-deficient mice.
Conclusions
These results demonstrated that Wnt signaling regulates MFSD2A-dependent TMZ delivery through a caveolae-mediated EC transcytosis pathway. Our findings identify Wnt signaling as a promising therapeutic target to improve drug delivery for GBM treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resourc…
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neuro-injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education…
- Department of Neurosurgery, Tangdu Hospital of the Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, China.
- Department of Obstetrics and Gynaecology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, 710005, China.
ORCID-Profile: Lei Zhang
Förderung
- National Natural Science Foundation of China
- Swedish Foundation for International Cooperation in Research and Higher Education (STINT) Mobility Program
- Swedish Cancer Foundation
- Swedish Science Council
- Natural Science Foundation of Shaanxi Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xie, Y., He, L., Zhang, Y., Huang, H., Yang, F., Chao, M., Cao, H., Wang, J., Li, Y., Zhang, L., Xin, L., Xiao, B., Shi, X., Zhang, X., Tang, J., Uhrbom, L., Dimberg, A., Wang, L., & Zhang, L. (2023). Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma. Neuro-Oncology, 25(6), 1073-1084. https://doi.org/10.1093/neuonc/noac288
Vancouver
Xie Y, He L, Zhang Y, Huang H, Yang F, Chao M, et al. Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma. Neuro-Oncology. 2023;25(6):1073-1084. doi:10.1093/neuonc/noac288
BibTeX
@article{Xie2023,
author = {Xie, Yuan and He, Liqun and Zhang, Yanyu and Huang, Hua and Yang, Fan and Chao, Min and Cao, Haiyan and Wang, Jianhao and Li, Yaling and Zhang, Lingxue and Xin, Lele and Xiao, Bing and Shi, Xinxin and Zhang, Xue and Tang, Jiefu and Uhrbom, Lene and Dimberg, Anna and Wang, Liang and Zhang, Lei},
title = {Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {6},
pages = {1073--1084},
doi = {10.1093/neuonc/noac288}
}
EUVIMED